Skip to main content
. 2023 Jun 15;12(12):4068. doi: 10.3390/jcm12124068
α-Gal A Alpha-galactosidase A
AUC Area under the curve
ERT Enzyme replacement therapy
FDCM Fabry disease cardiomyopathy
FSL Function–spacer–lipid
GB3 Globotriaosylceramide
MSD Meso Scale Discovery
ROC Receiver-operating characteristics